Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMears Regulatory News (MER)

Share Price Information for Mears (MER)

Share Price is delayed by 15 minutes
Get Live Data
416.50    -12.50 (-2.91%)
Bid:
415.50
Ask:
417.00
Spread: 1.50 (0.361%)
Market Cap: £331.30m
MER Live PriceLast checked at - London Stock Exchange

Intraday Mears Share Chart

Director/PDMR Shareholding

5 Jul 2013 07:00

RNS Number : 6674I
Mears Group PLC
05 July 2013
 



Mears Group PLC

("Mears" or the "Company")

5 July 2013

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons in accordance with DTR 3.1.2 R

The Company was notified on 4 July 2013 that David Miles, Chief Executive of Mears, had exercised share options over 292,504 ordinary shares of one penny each in the Company ("Ordinary Shares") as detailed below.

 

Date of grant

 

 

Scheme Type

Number of Ordinary Shares over which options were exercised

Exercise price per Ordinary Share (pence)

 

1 April 2004

Unapproved

30,453

1p

 

8 April 2005

Unapproved

7,220

1p

 

21 April 2006

Approved

10,000

300p

 

21 April 2006

Unapproved

6,087

1p

 

28 September 2007

Unapproved

50,045

1p

 

20 March 2008

Unapproved

151,149

1p

 

13 October 2008

LTIP

26,550

1p

 

28 October 2009

LTIP

11,000

1p

 

The Company was notified on 4 July 2013 that Alan Long, Executive Director of Mears, had exercised share options over 143,122 ordinary shares of one penny each in the Company ("Ordinary Shares") as detailed below.

 

Date of grant

 

 

Scheme Type

Number of Ordinary Shares over which options were exercised

Exercise price per Ordinary Share (pence)

 

21 April 2006

Approved

10,000

300p

 

21 April 2006

Unapproved

6,087

1p

 

28 September 2007

Unapproved

20,018

1p

 

20 March 2008

Unapproved

75,575

1p

 

13 October 2008

LTIP

26,550

1p

 

28 October 2009

LTIP

4,892

1p

 

On 4 July 2013, the Company was also informed that Mr Miles on 3 July 2013 sold 227,484 Ordinary Shares, at an average price of 387.31 pence per share. A significant part of the funds raised was to fund the cost of exercise together with the associated tax charge.

On 4 July 2013, the Company was also informed that Mr Long on 3 July 2013 sold 81,000 Ordinary Shares, at an average price of 387.31 pence per share, entirely funding the cost of exercise together with the significant associated tax charge.

As a result of these transactions:

·; Mr Miles has increased his interest in the Ordinary Shares of the Company from 110,000 to 175,020

·; Mr Long has increased his interest in the Ordinary Shares of the Company from 4,108 to 66,230

 

Mr Miles and Mr Long also have interests in share options under the LTIP scheme over 177,980 and 109,088 shares respectively. The options issued under the LTIP scheme are subject to the achievement of EPS and TSR performance conditions.

 

The exercise and disposal of the Ordinary Shares made by Mr Miles and Mr Long were in accordance with the trading plans Mr Miles and Mr Long entered into on the 28 June 2013.

 

Enquiries:

 

 

Mears Group PLC

David Miles, Chief Executive

Tel: +44(0)7778 220 185

Joint Broker - Investec

Keith Anderson/Daniel Adams

Tel: +44(0)20 7597 5970

Joint Broker - Canaccord Genuity

Piers Coombs/Lucy Tilley

Tel: +44(0)20 7523 8350

IR - Gable Communications

Tel: +44(0) 20 7193 7463

John Bick/Justine James

 

Tel: +44(0)7872 061 007

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAEXLESSDEAF
Date   Source Headline
30th May 20254:08 pmRNSTotal Voting Rights
8th May 20255:40 pmRNSExercise of options and PDMR dealing
1st May 20257:00 amRNSContract Award
28th Apr 20254:02 pmRNSAnnual Financial Report 2024 and Notice of AGM
23rd Apr 20254:31 pmRNSGrant of Long-Term Incentive Plan awards
23rd Apr 20254:29 pmRNSGrant of Deferred Bonus Share Plan awards
10th Apr 20257:00 amRNSFinal Results
2nd Apr 20259:18 amRNSTotal Voting Rights
31st Mar 20257:54 amRNSCompletion of Buyback programme
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20258:53 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202511:01 amRNSTransaction in Own Shares
17th Mar 202511:11 amRNSTransaction in Own Shares
17th Mar 202511:08 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20255:44 pmRNSResult of GM
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20252:13 pmRNSNotice of General Meeting
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.